Not applicableNo Longer AvailableNCT04646031
What this trial is testing
Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19
Who this might be right for
Covid19
Tasly Pharmaceuticals, Inc.
Showing 20 of 727 results